Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B Min ZhangJing LiFu-Sheng Wang Original Article Open access 20 February 2024 Pages: 435 - 448
Artificial intelligence in liver imaging: methods and applications Peng ZhangChaofei GaoXiaolong Qi Review Article 20 February 2024 Pages: 422 - 434
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis Aikaterini KamiliouVasileios LekakisEvangelos Cholongitas Original Article Open access 08 February 2024 Pages: 688 - 699
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence Benedikt SimbrunnerBenedikt S. HoferThomas Reiberger Original Article Open access 08 February 2024 Pages: 929 - 942
Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues Shiye YangHuoqi LiangZhibing Ming Letter to the Editor 08 February 2024
Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines Wei TengTing‑Tsung ChangJaw‑Ching Wu Correction 22 January 2024 Pages: 1066 - 1066
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes Xiaoyan MaYixuan ZhuJie Li Original Article 22 January 2024 Pages: 952 - 963
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan Ming-Lung YuChi‐Ming TaiCheng-Yuan Peng Original Article Open access 21 January 2024 Pages: 461 - 475
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease Shao-Wen WangTsung-Han HsiehJia-Horng Kao Original Article 16 January 2024 Pages: 943 - 951
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma Hyung-Don KimYoung-Gyu ParkChanghoon Yoo Original Article 12 January 2024 Pages: 973 - 983
FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease Lin LiLina KongQiang Meng Original Article 06 January 2024 Pages: 188 - 205
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease Haifeng WuMeng ZhouJinxia Liu Original Article 06 January 2024
Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation Shu FengXingming XieXueke Zhao Original Article Open access 03 January 2024 Pages: 1040 - 1052
Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis Jian-Xing LuoYang ZhangNe Xiang Orginal Article 02 January 2024 Pages: 63 - 72
Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma Cheng-Lei YangRui SongBang-De Xiang Original Article 30 December 2023 Pages: 73 - 90
Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply N. PfistererM. SchwarzT. Reiberger Letter to the Editor 23 December 2023 Pages: 706 - 707
Correction to: Targeting ferroptosis in hepatocellular carcinoma Yuqian MoZhilin ZouErbao Chen Correction 21 December 2023 Pages: 1065 - 1065
Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification? Mariana Michelle Ramírez-MejíaCarlos Jiménez-GutiérrezNahum Méndez-Sánchez Original Article 21 December 2023 Pages: 168 - 178
The safety profile of endoscopic variceal ligation in patients with esophageal varices Jake E. KrigeEduard G. JonasMarc M. Bernon Letter to the Editor 13 December 2023 Pages: 1060 - 1061
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study Daniel Q. HuangSally TranMindie H. Nguyen Original Article 11 December 2023 Pages: 540 - 549
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors Zhen-Xin ZengJia-Yi WuMao-Lin Yan Original Article 01 December 2023 Pages: 651 - 660
Correction to: Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma Ying XuGuangchao LuanTao Yang Correction 28 November 2023 Pages: 1064 - 1064
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age–period–cohort model for estimating demand from antecedent anti-HCV survey Ting-Yu LinHsiao-Hsuan JenYen-Po Yeh Original Article Open access 21 November 2023 Pages: 476 - 485
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway Fu WangWei-Qi XuJi-Min Zhu Original Article 20 November 2023 Pages: 636 - 650
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer Ao HuangDe-Zhen GuoJian Zhou Original Article 18 November 2023 Pages: 254 - 264
Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies Mi TangLiling XiongXiao Yang Review Article 13 November 2023 Pages: 50 - 62
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis Lanlan ChenYuexuan ZhaoGuoyue Lv Original Article 11 November 2023 Pages: 517 - 528
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated Sai LiYong Li Letter to the Editor 09 November 2023 Pages: 704 - 705
Autophagy and extracellular vesicles in the liver endothelium: friends or foes? Louise BiquardPierre-Emmanuel Rautou Editorial 09 November 2023 Pages: 1 - 3
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high? Fu-Sheng WangJing LiChao Zhang Letter to the Editor 31 October 2023 Pages: 296 - 298
Targeting ferroptosis in hepatocellular carcinoma Yuqian MoZhilin ZouErbao Chen Review Article 26 October 2023 Pages: 32 - 49
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma Shi-Chuan TangKai-Ling ZhangYong-Yi Zeng Original Article 25 October 2023 Pages: 623 - 635
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma Hiroyuki SuzukiHideki IwamotoTakumi Kawaguchi Original Article Open access 21 October 2023 Pages: 610 - 622
Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease Itsuo NagayamaKenya KamimuraShuji Terai Original Article 21 October 2023 Pages: 155 - 167
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations Ming ZhaoZhi GuoNing Lyu Consensus 21 October 2023 Pages: 4 - 31
Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study Binghan JinZhaoyuan WuJunfen Fu Original Article Open access 20 October 2023 Pages: 179 - 187
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis Jiaxi LiuPeng WangHaibo Shao Original Article 16 October 2023 Pages: 595 - 609
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32 Tae Hyung KimHyung Joon YimThe Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group Original Article 13 October 2023 Pages: 500 - 508
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study Jitao WangQiran ZhangWenhong Zhang Correction 12 October 2023 Pages: 1062 - 1063
Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity Xue ChengWei WangXiufang Weng Original Article 12 October 2023 Pages: 582 - 594
Outcomes of living donor liver transplantation for patients with APASL defined-acute-on-chronic liver failure Shweta A. SinghRicha BhargavaSubhash Gupta Letter to the Editor 09 October 2023 Pages: 294 - 295
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection Anika WrankeBenjamin HeidrichHeiner Wedemeyer Original Article Open access 03 October 2023 Pages: 1359 - 1367
Is laparoscopic liver resection more suitable for diabetic patients with hepatocellular carcinoma? The debate continues Shiye YangChunqiu Xia Letter to the Editor 01 October 2023 Pages: 292 - 293
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding Zhiying HeBingqiong WangHong You Original Article 29 September 2023 Pages: 1368 - 1377
How non-alcoholic fatty liver disease and cirrhosis affect the heart Søren MøllerSigne WieseJens D. Hove Review Article 28 September 2023 Pages: 1333 - 1349
Ending stigmatizing language in alcohol and liver disease: a liver societies’ statement European Association for the Study of the LiverAmerican Association for the Study of Liver DiseasesAsian Pacific Association for the Study of the Liver Editorial 27 September 2023 Pages: 1331 - 1332
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study Chin-I. ShihKuan-Ta WuMing-Lung Yu Original Article 25 September 2023 Pages: 138 - 154
Lymphatic drainage dysfunction is related to clinically significant portal hypertension Ruixue MaYasuko Iwakiri Editorial 24 September 2023 Pages: 1327 - 1330
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort Jing ZengQian JinJian-Gao Fan Original Article 20 September 2023 Pages: 1416 - 1428
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria Dawei DingGuanya GuoYing Han Original Article Open access 19 September 2023 Pages: 206 - 215